ACE2 and COVID-19: In addition, IFN has been found to stimulate the expression of ACE2 in epithelial cells of the respiratory tract [29] and, more recently, proteomic analyses revealed that in COVID-19 patients, different entry factors of SARS-CoV-2 are comprised in upregulated pathways [30].